GENETIC STRAINS AND STOCKS 



111 



Brh Dr. P. L. Broadhurst, Institute of Ko 



Psychiatry, Animal Psychology Lab- 

 oratory, Bethlem Royal Hospital, 

 Monks Orchard, Beckenham, Kent, Kx 



England. 



Bw Dr. L. G. Browman, Montana State 



University, Missoula, Montana. Mai 



Cp Dr. A. B. Chapman, Department of 

 Genetics, University of Wisconsin, 

 Madison, Wisconsin. Mor 



Ct Dr. W. F. J. Cuthbertson, Glaxo 



Laboratories, Middlesex, England. N 



Dem Dr. E. Dempster, Department of 

 Genetics, University of California, 

 Berkeley, California. 



Do Dr. William G. Downs, Tennessee Ne 



Polytechnic Institute, Cookeville, Ten- 

 nessee. Nl 



Dr Prof. Dr. Med. Herman Druckrey, 

 Laboratorium D. Chirurg. Univ. Klink., 

 Hugstetterstrasse 55, Freiburg im Breis- 

 gau, Germany. 



Du Dr. Wilhelmina F. Dunning, Experi- Ow 



mental Cancer Research Laboratory, 

 University of Miami, Coral Gables, 

 Florida. Rot 



Fu J. Furth, M.D., Roswell Park Memorial 

 Institute, Buffalo, N.Y. 



Gm J. P. W. Gilman, D.V.M., Ontario 



Veterinary College, Guelph, Ontario, Seg 



Canada. 



Gor Dr. W. S. Gordon, Director, Agricultural 

 Research Council, Field Station, Com- 

 pton, near Newbury, Berkshire, Eng- Ss 



land. 



Hi Dr. Russell Hilf, The Squibb Institute Sy 



for Medical Research, New Brunswick, 

 New Jersey. Ta 



Hun Dr. H. R. Hunt, Department of Zoology, 



Michigan State University, East Lan- To 



sing, Michigan. 



Kl Drs. G. and E. Klein, Department of 

 Cell Research, Karolinsha Institute, 

 Stockholm, Sweden. 



Dr. Henry Kohn, Radiological Labora- 

 tory, University of California Medical 

 Center, San Francisco 22, California. 

 Dr. W. Eugene Knox, Harvard Medical 

 School, Harvard University, Cambridge, 

 Massachusetts. 



Microbiological Associates, Inc., 4648 

 Bethesda Avenue, Bethesda 14, Mary- 

 land. 



Dr. Pablo Mori-Chavez, 779 Sanchez- 

 Carrion, Lima, Peru. 

 Genetics Research Unit (Dr. D. Bailey), 

 Laboratory Aids Branch, National 

 Institutes of Health, Bethesda 14, 

 Md. 



Dr. Howard Newcombe, Atomic Energy 

 of Canada, Chalk River, Canada. 

 R. L. Noble, M.D., Department 

 of Medical Research, The Collip 

 Medical Research Laboratory, The 

 University of Western Ontario, London, 

 Canada. 



Dr. Ray D. Owen, Division of Biological 

 Sciences, California Institute of Tech- 

 nology, Pasadena 4, California. 

 Dr. med. W. Rotzsch, Physiologisch- 

 Chemisches, Institut der Universitat 

 Leipzig, Liebigstraat 16, Fernruf 311 

 14, Leipzig, Germany. 

 Dr. Albert Segaloff, Division of Endo- 

 crinology, Alton Ochsner Medical 

 Foundation, 1520 Jefferson Hwy., New 

 Orleans 21, Louisiana. 

 Dr. W. K. Silvers, The Wistar Institute, 

 Philadelphia 4, Pennsylvania. 

 Dr. K. L. Sydnor, University of 

 Chicago, Chicago, Illinois. 

 Dr. Martha J. Taylor, Pathology 

 Division, Fort Detrick, Maryland. 

 Miss Eva L. Tonks, Research Depart- 

 ment, Birmingham (Dudley Road) 

 Group of Hospitals, Birmingham & 

 Midland Eye Hospital, Church Road, 

 Birmingham 3, Alabama. 



m. GUINEA PIGS 



The genetic material for guinea pigs is very limited in this country as well as 

 elsewhere. Apparently only three established inbred strains exist; two of the three are 

 the remaining strains from the thirty-five original ones started by the U.S. Department 

 of Agriculture in 1906 and later developed by Wright, 1445 - 1447 and the third has been 

 developed by Dr. O. Miihlbock more recently. Several strains are in the process of 

 development, but little is known about them, and, except for the waltzing and silvering 

 stocks, no stocks of genetic significance are maintained. Renewed interest seems to be 

 developing for the use of inbred guinea pigs for immunogenetic work, so the future 

 does hold some promise for the increased use of this species in mammalian genetics. 



